Company intelligence / Profile preview

Synterys

California, United Statesvistagen.com ↗

Ownership: Private
Development stage: Other

Overview

Synterys provided medicinal chemistry and collaborative drug discovery services. In 2011, it entered into an agreement with VistaGen Therapeutics to support stem cell-based drug rescue programs by advancing small molecule candidates through preclinical development. No clinical results specific to Synterys are available.

Therapeutic areas: Other
Modalities: Small molecule
Industry: Drug Discovery Services

Partnerships

VistaGen Therapeutics (strategic medicinal chemistry services agreement)

Beyond the preview

Go deeper on Synterys.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Synterys.

Explore the full profile